Background. Adenoviruses are significant pathogens for the immunocompromised, arising from primary infection or reinfection. Serotyping is insufficient to support nosocomial transmission investigations. We investigate whether whole-genome sequencing (WGS) provides clinically relevant information on transmission among patients in a pediatric tertiary hospital.
In immunocompromised pediatric patients, adenovirus presents a particular problem, accounting for 15% of diarrhoea in pediatric oncology patients [6] . Adenoviremia is seen in 11% of pediatric human stem cell transplant (HSCT) recipients and is associated with significant costs due to increased time spent in hospital and antiviral drug costs [7] . There are limited treatment options (cidofovir [8] , brincidofovir [9, 10] , and HAdV-specific T cells [11, 12] ), and thus there is increased mortality from HAdV in pediatric HSCT recipients. Immunocompromised individuals may also serve as a sentinel population for the detection of new strains, because these individuals may be simultaneously infected with more than 1 genotype, providing circumstances in which recombination may occur [13] . Identifying these patients sooner may be important for infection control, to prevent onward transmission of new genotypes.
Studies of reported HAdV outbreaks in children's hospitals [14] [15] [16] have relied on serotyping or molecular typing to investigate the epidemiological linkage of cases. Human mastadenovirus genotyping with small, single-gene regions can be misleading and produce inconsistent molecular and serological typing profiles compared with the WGS [17, 18] . Whole-genome sequencing increases the resolution of molecular epidemiology, and for other viruses it has distinguished between patient-topatient transmission [19] and cases of importation of virus from outside sources (eg, family members) [20] . Few hospitals perform HAdV genotyping in routine diagnostic testing, making it difficult to compare data in different patient populations.
In 2010, we introduced selective molecular hexon genotyping of adenovirus infections as a means of identifying putative healthcare-associated infections (HCAIs), particularly among patients undergoing HSCTs. However, the data were insufficient to resolve whether infections were truly nosocomial. With methods that allow high-throughput WGS directly from clinical material [21] [22] [23] [24] , we examine the utility of WGS for the identification and management of adenovirus HCAIs. To do this, we optimized HAdV genome sequencing using 3 cultured isolates, with specific ribonucleic acid (RNA)-bait-based target enrichment [22] . After this, we extracted DNA directly from clinical samples and sequenced all available adenoviremias and associated HAdV-positive samples occurring over a 15-month period between January 2015 and March 2016 (101 samples from 37 patients) in a tertiary care hospital in London, United Kingdom (UK), and 6 archived DNA samples from 5 patients collected between January 2011 and July 2012. Many of the samples sequenced had been previously hexon genotyped; additional hexon genotyping data were available for other patients, although the clinical samples had been discarded.
METHODS

Ethics and Samples
Samples were submitted to the UCL Infection DNA Bank for use in this study and supplied in an anonymized form. The National Research Ethics Service (NRES) Committee LondonFulham (REC reference: 17/LO/1530) approved the use of these specimens for research. These samples were collected from patients under 18 years of age as part of standard clinical care between January 2011 and July 2016. All samples were residual diagnostic specimens obtained from patients with confirmed adenovirus infections [25] . Data on hexon genotype were available for patients who had undergone HSCT and were A31 positive between 2011 and mid-2016. Clinical samples, DNA extraction, and hexon genotyping are described in Supplementary Table 1 and Supplementary Methods. Based on previous experience of the initial sensitivity of enrichment WGS, we predominantly selected whole blood samples for this study with reported viral loads of >50 000 copies/ mL. Six archived DNA samples (extracted from whole blood) from 2011 and 2012 were also available from 5 patients with adenoviremia, with reported virus loads ranging from 4292 to 1 000 000 copies/mL.
For optimization, 3 typed strains, D9 ATCC VR-1086 and E4 ATCC VR-1572 (both cultured in Vero cells) and F40 ATCC VR-931 (cultured in HEK-293 cells), that had each been passaged 3 times were sequenced. Cultured adenovirus was purified using OptiPrep density gradient medium (Sigma-Aldrich), following the manufacturer's instructions.
SureSelect Bait Design
One hundred twenty-mer RNA baits were designed, using an in-house perl pipeline with a tiling factor of 6× (each position in a given genome is covered by 6 unique bait designs), against all whole human adenovirus sequences and supplementary hexon, penton, and fiber gene sequences available in GenBank (accessed October 29, 2015) . The bait design (Supplementary File 1) was uploaded to SureDesign, and biotinylated RNA oligonucleotides (baits) were synthesized by Agilent Technologies.
Sequencing
Hybridization and library preparation was performed as previously described [23] . In brief, extracted DNA was sheared by acoustic sonication (Covaris e220; Covaris Inc.). The DNA fragments underwent end-repair, A'-tailing, and (Illumina) adaptor ligation. The DNA libraries were hybridized with the biotinylated RNA baits for 24 hours at 65°C and subsequently bound to MyOne Streptavidin T1 Dynabeads (ThermoFisher Scientific). After washing, libraries were minimally amplified (12-22 cycles) to generate sufficient input material for Illumina sequencing. Samples were multiplexed to 48 samples per run. Paired end sequencing was performed on an Illumina MiSeq using 500 v2 Reagent Kit (catalog no. MS-102-2003; Illumina). Base calling and sample demultiplexing were performed as standard on the MiSeq, and paired FASTQs were generated for each sample. In instances in which samples from different patients clustered, a second sequence, when additional clinical material was available, from each patient was analyzed in a different run to ensure that the result was not due to sample mix up.
Genome Mapping, Assembly, and Phylogenetic Analysis
Sequence data were analyzed using CLC Genomics Workbench (QIAGEN) version 8.5.1. Reads were quality trimmed and adapter sequences were removed. Trimmed reads were mapped to a curated reference list of complete adenovirus genome sequences in GenBank as of November 29, 2015 (n = 113). The CLC Genomics Workbench Microbial Genome Finishing Module was applied for de novo assembly of samples with predicted 100% genome coverage (based on mapping to reference genomes). De novo assemblies were accepted if a single contig of at least 34 000 base pairs could be generated. De novo assembly of 2 high coverage genomes produced identical consensus sequences to mapping to the closest reference sequence; therefore, we mapped all sequences to the closest reference to produce consensus sequences to ensure consistency of mapping methodology between high and low coverage samples. Genome assemblies are available at the European Nucleotide Archive, study accession PRJEB24711. Bait sequences are included as Supplementary Data.
All reads mapping to the reference list (filtered reads) were taken forward for remapping to the best reference match (length fraction 0.8, similarity fraction 0.8), and a consensus sequence was generated. The best reference match was used to assign a genotype to each sample. Reads that did not map were assumed to be off-target (not adenovirus). Mapping parameters were as previously published [26] , except for a minimum contig size of 500. The mapping mode was set to map reads back to contigs (slow). Minority variants were called if (1) the base was sequenced at least 6 times, (2) the variant was present in ≥6 (including 2 forward and 2 reverse) reads, and (3) it was present at a frequency ≥2%. The read direction filter significance was 0.05, and the relative read direction filter significance was 0.01. Full and partial consensus genomes were aligned using MAFFT [27] default settings, with manual correction in MEGA6 if required [28] . Phylogenetic trees were created using RAxML BlackBox [29] .
Nucleotide Diversity
Within-host nucleotide diversity was calculated for 12 samples from 5 patients with average read depths ≥1000×. For these 12 samples, reads were reference-mapped, and base counts at each position were extracted to calculate within-host nucleotide diversity (π), defined as the average number of nucleotide differences between reads at a site [30] . Bases sequenced at ≥2× were used for imputation. Strand bias and random error rates were estimated and corrected for using maximum likelihood methods [31] .
To separate genotypes present in samples believed to contain mixed infections, all samples were first mapped to a panel of references, where 80% of each read mapped with minimum 80% identity. Samples with high coverage mapping to different genotypes were then remapped to the top 2 references, where ≥95% of each read was mapped with a minimum of 95% sequence identity to reduce cross-mapping between the 2 reference genotypes. BAM files were generated containing reads mapping to either reference, and nucleotide diversity was calculated for each to determine single-genotype adenovirus diversity. Pairwise differences between genomes were calculated using UGENE, version 1.26.1 [32] .
Statistical Analysis
One-way, single-factor analysis of variance with correction for multiple testing was used to compare the success of sequencing between genotypes. Figures were generated and statistical analyses were performed in MATLAB 2015b.
RESULTS
Success of the Sequencing Methodology
The WGS performance is shown in Supplementary Table 2. All 3 cultured samples gave genome coverage of 100% with mean read depths of 1000×. Near-complete genomes (>80% coverage) were recovered from 56 of 107 clinical samples, all of which had >10× read depth. All 23 nonspecies C viruses produced full genomes. Two clinical samples failed, both with virus loads below 50 000 copies/mL. The minimum viral load needed for >80% coverage at any depth was found to be species-dependent (Supplementary Table 3 ). Despite similar average virus loads and mean read depths, species C viruses yielded lower percentage genome coverage than non-C viruses (P = .00008), with lower percentage on-target reads (P = .016, not significant) ( Figure 1, Supplementary Figure 1 ). Whole genomes were recovered from 36 of 85 species C samples. In 9 of 107 samples, all from a single patient, we identified mixed infections with at least 2 HAdV genotypes.
In total, we identified 7 genotypes among 105 clinical samples on the basis of similarity to reference HAdV genomes, the majority of which were species C ( Figure 2) ; in 2 clinical samples, there were no adenovirus-specific reads to use in molecular genotyping. Genotypes A31, B3, C1, C2, C5, and E4 were detected in whole blood; genotype F41 was detected in stool or stool-contaminated urine only ( Figure 3 ). Although genotype Percentage of the genome covered relative to calculated genome copies (log 10 ) in each sequencing reaction. There is a relationship between log 10 genome copies input and genome coverage for adenovirus species C (genotypes 1, 2, and 5), although not other genotypes.
C2 was detected in 36.2% of the samples sequenced, it was only present in 7 of 27 (26%) patients with adenoviremia. The large number of C2 samples from these 7 patients reflects the long duration of viremia during the year of sampling. No patients carried any of the previously reported polymerase mutations associated with drug resistance [33] .
Molecular Epidemiology and Sample Phylogenies
Focusing on sequences with ≥80% genome coverage (excluding identical sequences from sequentially sampled patients), we first constructed a maximum likelihood phylogenetic tree of 37 adenovirus genomes (Supplementary Figure 2) . The tree confirmed genotyping based on hexon sequences. Two clusters, defined as monophyletic groups comprising 2 or more samples from at least 2 patients with bootstrap support ≥90, were observed ( Figure 4) . Analysis of these together with available GenBank genomes confirmed one A31 (*1) and one C1 (*2) cluster. The putative clusters and phylogenies are shown for each species (Figure 4) . Figure 4A shows the phylogenetic tree of A31 sequences including cluster *1. This cluster comprised patients P8, P7, P18, and P25. All 4 were chronically immunosuppressed and had been under the same medical team and on the same ward at different times over a 5-year period (temporal relationship shown in Figure 5 ). Patient 19 had also been on the same ward and under the same team during this period, but the patient was infected with a genotype A31 virus that was distinct from the monophyletic cluster ( Figure 5 ). Patients 29 and 35 who also had distinct A31 viruses had had periods of time under the same team and were briefly on the same ward as the others, although neither were A31 positive during these periods. Hexon typing of blood and/or stool showing infection with A31 was Figure 4 . Phylogenies of adenovirus types sequenced as part of this study. Sequences were aligned using MAFFT, manually edited in MEGA7 if necessary, and maximum likelihood trees were created using RAxML BlackBox, 500 bootstraps. Branch support values higher than 70 are shown. Sequences were considered clusters if a branch contained at least 2 GOSH samples from at least 2 patients and had bootstrap support greater than 90. (A) Phylogeny of adenovirus A31. Three of the 8 A31 cases (patients P19, P29, and P35) can be excluded from possible patient-to-patient transmission phylogenetically. Nine A31 samples from 4 patients (P7, P8, P18, and P25 in cluster *1) cluster together phylogenetically and have low pairwise diversity to other another, but they are separated temporally (P18 samples collected in 2011). (B) Phylogeny of genotype B3 sequenced from patient samples, which cluster separately and are thought to be unrelated. (C) Phylogeny of adenoviruses of genotypes C1, C2, and C5 from the same hospital. Sequences from patient 5 do not cluster monophyletically. Two patients (23 and 43) infected with adenovirus C1 cluster together (*2) and were shown by ward movement analysis to have had contact within the hospital. (D) Phylogeny of E4 sequences from a single patient, which are more similar to wild-type E4 sequences taken from GenBank than vaccine-strain genomes. (E) Phylogeny of F41 sequences from the hospital and GenBank.
available for 15 patients (including patients 19 and 8) who had been on the same ward as the patients in the cluster ( Figure 5) ; however, for 13 of these patients, no samples were available for WGS. Overall, P18 was likely to have been the originator of the cluster. Although discharged in 2012, 3 years before P8, the next patient in the cluster became positive, and transmission of the A31 cluster may have been sustained by other patients during this period ( Figure 5 ). P8 became A31 hexon-positive (stool) in a different ward in early 2015, shortly after admission. However, our data confirms that at least 3 other A31 strains were present at various times in children on this ward, and because no WGS data is available for the other A31-infected patients or the January 2015 P8 samples, it is not possible to determine the exact route of transmission from P18 to P8; P8 may have been infected by an unknown route with this A31 strain at presentation, or they may have been infected with 2 different A31 strains during their inpatient stay (the second, falling in cluster *1, captured by WGS). The possibility of environmental transmission [34] remains because hexon typing of samples taken in 2011 from cubicles on the ward were A31 positive, although rooms were screened and recleaned until they became adenovirus-negative by polymerase chain reaction (PCR).
Within and Between Patient Differences
To verify the cluster analyses, we calculated pairwise nucleotide differences for consensus adenovirus sequences from same-patient sequential samples, samples from identified clusters, newly sequenced samples that do not cluster, and unrelated HAdV sequences ( Figure 6A ). The pairwise differences between sequences in the A31 cluster were identical or nearly identical (≤3 nucleotide differences for cluster *1 sequences) to the within-patient differences ( Figure 6B ). In contrast, the lowest pairwise distance of samples in the cluster to sequences from patients 19, 35, and 29 were 55, 148, and 44, respectively. The monophyletic cluster of C1 sequences comprising patients P23 and P43 and a publicly available sequence collected in 2003 differed by 33-39 nucleotides compared with 4 nucleotides for genotype C1 within-patient variation ( Figure 6B ). Pairwise differences between sequences of samples from GOSH and GenBank, divided by species. Bars marked 'Within patient diversity' show pairwise differences between samples from the same patient. Bars marked 'Between patient diversity' show pairwise differences (1) between samples from different patients at GOSH or (2) between GOSH sequences and sequences available in GenBank. Bars marked 'Between genotypes (same species)' show the number of differences between sequences of 2 closely related genotypes within the same species: the differences between A31 and A61, B3 and B7, C1 and C2, and F40 and F41. Bars marked 'Mixed infection (same species)' show the within-patient pairwise differences of sequences from patient 5, which are hypothesised to be a mixed genotype infection. Bars marked 'Within cluster diversity' show the pairwise differences between samples from different patients in clusters *1 (A31) and *2 (C1), respectively ( Figure 4 ). For genotype E4, the between patient (including GenBank) difference reflects the change in circulating E4 sequence diversity since the vaccine strain was isolated from a 1950s field strain. (B) Zoomed in view of data from 6A, showing pairwise differences up to 100 nucleotides between sequences of samples from GOSH and GenBank from species A and C, including samples from cluster *1 (A31) and putative cluster *2 (C1). The number of within-patient pairwise differences and between-patient pairwise differences for phylogenetically clustered samples overlaps for patients infected with genotype A31 (cluster *1). However, for patients infected with genotype C1, the within-patient pairwise differences (<5 differences) are considerably fewer than the putatively clustered C1 sequences (cluster *2), which differ by 33 nucleotides.
Neither patient was on the same ward, nor were they looked after by the same team. The 2 genotype F41 patient samples (P27 and P28; Figure 4E ) shared a unique single nucleotide deletion at position 1074 located in an intron of gene E1A, which distinguished them from other F41 sequences; however, they did not form a well supported monophyletic cluster, with a pairwise distance of 20 and no history to link them. The close clustering in these examples is likely to reflect the paucity of UK HAdV genome sequences and the probable existence of local variants that are more closely related than other non-UK viruses.
As shown in Figure 4C , the species C sequences partition into genotypes 1, 2, and 5, except for sequences from patient P5. The polyphyletic sequences from patient 5 suggested a mixed-genotype infection, with some sequences clustering with C5 genomes (eg, GOSH_2055, 2074, 2054, and 2051), 2 sequences with C1 genomes (GOSH_2049, 2052), and a further 2 sequences (GOSH_2005 and GOSH_2007) clustering in an intermediate position. By mapping reads specifically to individual adenovirus C1 or C5 genomes (Supplementary Figure 3) and creating a phylogeny, we confirmed from the allele frequencies for each genotype that a mixture of C1 and C5 infection, rather than a recombinant virus, was likely to be present. The pairwise differences between consensus sequences from patient 5 samples were intermediate in frequency between genomes from different patients and genomes from different genotypes, consistent with the hypothesis that this patient had a mixed-genotype infection ( Figure 6A ).
Finally, we calculated adenovirus within-host nucleotide diversity for 8 samples from this patient. We also calculated within-host nucleotide diversity for samples of comparable depth from patients infected with single genotypes: A31 (P35, GOSH_2094), B3 (P3, GOSH_2004), C1 (P23, GOSH_2050), and C2 (P14, GOSH_2033). When total reads mapping to any adenovirus genome were considered, samples from patient 5, apart from the final sample, had high nucleotide diversity ( Figure 7 ). When reads were mapped stringently to either the C1 or C5 genome, the nucleotide diversity dropped to be comparable with the single genotype infections from other patients. This supported our inference of a mixed genotype infection in this patient, which resolved to a single genotype infection by the final sample (GOSH_2055). The proportion of reads mapping to C1 and C5 adenovirus fluctuated over time within patient 5 (Supplementary Figure 4) . By day 25 of PCR-detectable viremia (sample GOSH_2055), the sequence had returned to a C5 genotype, and the secondary C1 genotype appears to have been purged from the population.
DISCUSSION
Whole-genome sequencing with phylogenetic analysis identified a monophyletic cluster of patients infected with adenovirus A31, which was potentially explained by nosocomial transmission. For patients P7, P8, and P25, standard infection prevention and control (IPC) methods had already flagged up the likelihood of HCAI. The link of P18 to the other 3 was unexpected, given that there was no overlap in the times that P18 was an inpatient with the other three. Previous hexon typing had shown that A31 infections were present among patients on this ward. However, the high degree of hexon sequence conservation makes it difficult to discriminate between related and unrelated strains. Patient P19, who was also A31-positive, was in the same ward as P18 in 2012 and was still A31 positive in 2015, but the patient had a phylogenetically distinct strain that was not part of cluster 1. P19's virus differed from both P18 and P8 by 55 single nucleotide polymorphisms (SNPs). Despite the passage of time, P18 and P8 sequences differed by only 2 SNPS. These data underline the superiority of WGS over hexon typing for HCAI investigation, with the latter showing low specificity for establishing relatedness. Without genome sequences from the many A31 cases that occurred on this ward between the inpatient stays of P18 and P8, we cannot be sure how the virus came to be transmitted over a 3-year period. There is evidence for persistence of adenovirus DNA on environmental surfaces for up to 3 months after infection [35, 36] , despite extensive cleaning [37] . This raises the possibility of transmission from the environment or fomites; A31 virus had been detected in 2 ward environments during suspected-outbreak management in 2011, and children with A31 were present on the ward ( Figure 5 ) or in outpatient follow-up (data not shown) throughout. Community transmission also remains a possibility.
Two other putative clusters, the C1 cluster *2 and an F41 cluster, were identified. In both cases, the pairwise distance between viruses was considerably higher than is seen for within-patient adenovirus variation. For cluster *2, an unrelated adenovirus sequence collected in the United States in 2003 [38] separated viruses P23 and P43. The F41 sequences, despite being genetically relatively distant, share a unique deletion that was not present in GenBank and may be a locally circulating variant. There are currently fewer than 10 species A, 10 genotype C1, and 15 species F adenovirus genomes publicly available. With additional sequences from both local and wider geographical areas, the granularity of data available (including the frequency of indels at particular loci) will increase and phylogeny will become more useful for identifying putative transmission events.
The availability of whole genomes and variant data also allowed us to identify a mixed genotype C1/C5 infection in patient 5. Adenoviremia was detected in patient 5 within 2 weeks after HSCT, and this patient ultimately died of overwhelming adenovirus infection. Although mixed adenovirus infection of fecal [39] and urine [40] samples is commonly reported, this is the first reported case (to our knowledge) of a mixed adenoviremia. Whether the dual infection contributed to the severity of outcome is not clear. Additional WGS should elucidate whether dual adenoviremia is an indicator of poor prognosis.
The WGS approach presented here shows the utility of target-enriched adenovirus sequencing in a clinical setting directly from clinical samples [41] , without culture [42] or specific PCR amplification [43] . Although this first analysis reveals the need for redesign of the baits to better capture species C adenoviruses, this process is now well established and has been successfully applied to other DNA ( [22, 23, 44] ) and RNA ( [45, 46] ) viruses.
CONCLUSIONS
Our data show that WGS was able to confirm nosocomial transmission of HAdV infection in immunosuppressed patients. We uncovered a linked case that had not previously been suspected and that suggested sustained nosocomial transmission occurring over several years. Although adenovirus is recognized to cause serious disease in children [7] , better data are needed to determine whether, and from where, these are acquired, because transmission within hospitals is a recognized phenomenon (including contact in in-and outpatient environments [36, 47] ).
Our data suggest that the extent to which this happens may be greater than hitherto suspected, and WGS data are necessary to identify the measures needed to interrupt spread of this virulent virus. Human mastadenovirus genome deep-sequencing also allows rapid identification of potentially mixed infections, which demonstrate recognizably greater nucleotide diversity than single strain infections, whereas adenovirus detection and PCR alone cannot. The clinical implications of mixed infections are as yet unknown, but their identification may be important if, as with human cytomegalovirus, they are associated with poorer prognosis [48] . With decreasing costs, improved methods, and increasing automation, adenovirus genome sequencing offers a realistic potential for better understanding nosocomial transmission and pathogenesis.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and Triangles show nucleotide diversity of reads mapped stringently to genotype C1. Squares show nucleotide diversity within reads mapped stringently to genotype C5. Samples from other patients with single genotype infections, sequenced to comparable depth, show much lower total-adenovirus reads nucleotide diversity than patient 5. When reads from patient 5 are mapped stringently to either adenovirus genotype C1 or genotype C5, the nucleotide diversity is more comparable to that seen in other patients with single genotype infections (A31, B3, C1, and C2; right of graph). This suggests that high nucleotide diversity within patient 5 genomes is accounted for by the presence of a mixed-genotype C1 and C5 coinfection.
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